遺伝子系図市場-世界の産業規模、シェア、動向、機会、予測、2018～2028年、検査タイプ別、用途別、エンドユーザー別、地域別、競合

遺伝子系図の世界市場は、2022年に9億5,939万米ドルと評価され、2028年までのCAGRは7.81%で、予測期間中に目覚ましい成長を予測しています。

遺伝子系図は、遺伝的祖先検査としても知られ、家族の研究、その歴史、血統の追跡を掘り下げる魅惑的な分野です。魅力的な詳細を発掘し、魅力的な人生の物語に変えるために、歴史的な内容を調査・探求する細心のプロセスを伴います。この深い探求は、私たちの祖先-彼らがどこから来て、どのような人生を送り、どのような文化的伝統を守ってきたのか-を深く理解することにつながります。

遺伝子系図は、私たちのルーツとつながり、民族の伝統を守ることを可能にするだけでなく、私たちの医学史の謎を解き明かし、長年の家族の神話を否定する上で重要な役割を果たします。家系図を作成し出版することで、私たちは先祖の遺産を大切にし、後世に伝えることができるのです。家系図の分野は世界各地で広く普及しており、家系図製品やサービスの成長に拍車をかけています。さらに、遺伝子検査やDNA検査などの医療検査に対する需要が様々な業界で高まっていることから、系図市場は力強い成長を遂げています。系図に対する意識が高まり続ける中、自分の家系を辿り、先祖の物語を明らかにしようとする個人が増えています。この動向は特に中国で顕著であり、人口のかなりの部分が歴史的記録の欠如による課題に直面しています。

市場促進要因

DNA検査需要の急増

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の遺伝子系図市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別（常染色体DNA検査、Y染色体DNA検査、ミトコンドリアDNA検査）
  • 用途別（遺伝・遺伝疾患、父系・母系、祖先の起源、その他）
  • エンドユーザー別（消費者向け直接検査会社、法執行機関、調査機関・学術機関、その他）
  • 地域別
  • 企業別（2022年）
• 市場マップ

第6章 北米の遺伝子系図市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の遺伝子系図市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋の遺伝子系図市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の遺伝子系図市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの遺伝子系図市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 検査タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の展開
• 合併・買収
• 製品発表

第13章 遺伝子系図の世界市場のSWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• 23&Me Inc.
• Ancestry.com
• MyHeritage
• Sequencing. Com
• FTDNA
• DNASolves
• Living DNA
• FindmyPast
• Familysearch
• Geneanet

第16章 戦略的提言

当社について＆免責事項

Global Genetic Genealogy Market has valued at USD 959.39 Million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.81% through 2028. Genetic Genealogy, also known as genetic ancestry testing, is a captivating field that delves into the study of families, their history, and the tracing of their lineages. It involves a meticulous process of researching and exploring historical content to unearth fascinating details and transform them into engaging life stories. This profound exploration provides a deep understanding of our ancestors - where they came from, how they lived their lives, and the cultural traditions they upheld.

Not only does genetic genealogy allow us to connect with our roots and preserve ethnic traditions, but it also plays a vital role in unraveling the mysteries of our medical history and debunking long-standing family myths. By assembling and publishing family history books, we can ensure that the legacy of our ancestors is cherished and passed down to future generations. The field of genealogy has witnessed widespread popularity in different parts of the world, fueling the growth of genealogy products and services. Moreover, with the increasing demand for medical testing, such as genetic and DNA testing, across various industries, the genealogy market is experiencing strong growth. As awareness about genealogy continues to soar, more individuals are seeking to trace their lineages and uncover their ancestral stories. This trend is particularly evident in China, where a significant portion of the population faces challenges due to the lack of historical records.

Key Market Drivers

Surging Demand for DNA Testing

DNA carries essential genetic information for the growth, functioning, and reproduction of living organisms. DNA testing is conducted to detect any alterations in genetic material, aiding in the identification of various genetic risks associated with health conditions. This information enables individuals to make informed decisions about necessary lifestyle changes to achieve their health and wellness goals. Each person possesses a unique set of genetic variants, contributing to their individuality.

DNA testing plays a crucial role in solving criminal cases by establishing the presence of individuals at crime scenes. Forensic investigators collect samples such as blood, hair, or tissue from the crime scene, which are then analyzed in laboratories to verify the identity of the involved individuals. The results of DNA testing are generally accepted as factual evidence in court, providing a credible basis for judicial and law enforcement decisions.

Moreover, DNA testing aids in tracing and identifying ancestors, helping individuals discover lost relatives and understand their genetic heritage. It also assists in detecting life-threatening diseases like cancer and the presence of viruses in the body. Additionally, DNA testing can determine biological parentage and resolve legal cases. Furthermore, it provides detailed reports on genetic predispositions related to health, fitness, and nutrition, facilitating personalized lifestyle adjustments and health check-ups. The aforementioned factors contribute to the increasing demand for DNA testing, thereby driving the growth of the global genealogy products and services market.

High-End Investment for Research and Development Activities

Significant investments by leading authorities and organizations in research and development activities have paved the way for the remarkable growth of the genetic genealogy market. These investments are driven by the ever-increasing need to enhance our understanding of genetic ancestry and unlock the full potential of personalized medicine.

By leveraging advanced genetic testing and analysis techniques, genetic genealogy not only improves the quality of healthcare services provided to patients, but also opens up new possibilities for preventive care and targeted treatments. With the rising demand for high-quality healthcare services and the growing interest in personalized medicine, the genetic genealogy market is poised for lucrative opportunities and sustained growth.

The integration of genetic genealogy into healthcare systems has the potential to revolutionize patient care. By providing healthcare professionals with comprehensive genetic information, they can make more informed decisions about treatment plans, medication choices, and disease prevention strategies. This personalized approach to healthcare has the potential to greatly improve patient outcomes and overall quality of life.

Moreover, the advancements in genetic genealogy have also sparked interest among individuals seeking to delve into their own genetic heritage. People are now able to uncover fascinating insights about their ancestry, connecting with distant relatives, and exploring their family histories in ways that were previously unimaginable. This has created a burgeoning market for consumer genetic testing kits and services, further driving the growth of the genetic genealogy industry.

The genetic genealogy market is experiencing rapid expansion due to significant investments in research and development, the increasing need for genetic understanding, and the potential for personalized medicine. As the field continues to evolve, it holds tremendous promise for improving healthcare outcomes, enabling preventive care, and satisfying the curiosity of individuals eager to discover their genetic roots.

Ongoing Development of Pharmacogenomics

The field of pharmacogenomics, which is the study of how genetics influence the effects of medication on the human body, is experiencing continuous growth to meet the diverse and evolving needs of the global population. This rise can be attributed to the increasing awareness among consumers about the advantages of preventive healthcare and the potential of personalized medicine. By integrating genetic information into healthcare practices, there is a promising opportunity to revolutionize the way we approach treatment and improve patient outcomes on a larger scale.

As we delve deeper into the intricate relationship between genetics and medication response, the potential for tailored treatments based on an individual's genetic profile becomes increasingly apparent. This personalized approach has the potential to optimize drug efficacy, minimize adverse reactions, and ultimately enhance patient well-being. With advancements in technology and the availability of genetic testing, the demand for genetic genealogy services is expected to witness significant growth in the next five years.

By harnessing the power of pharmacogenomics, healthcare professionals can make more informed decisions about medication choices, dosages, and treatment plans. This precision medicine approach holds great promise in improving patient outcomes, reducing trial and error in treatment, and ultimately shaping the future of healthcare. Through the integration of genetic information and the continued advancement of pharmacogenomic research, we are poised to unlock a new era of personalized medicine that caters to the unique needs of each individual.

Increasing Demand of Personalized Treatment

By harnessing the power of genetic genealogy, healthcare facilities are empowered to deliver highly personalized treatment to their patients, aligning with the highest standards of quality in healthcare provision. This approach enables the development of effective products and services tailored specifically to the unique needs of each patient, ensuring optimal outcomes and improved overall healthcare experiences.

With major players in the industry embracing the study of genetic genealogy, such as leading research institutions and pharmaceutical companies investing in cutting-edge technologies, the future of personalized medicine looks promising. The integration of genetic insights into healthcare practices opens up new avenues for precise diagnostics, targeted therapies, and preventive interventions. Patients can benefit from early detection of genetic predispositions, personalized treatment plans, and improved disease management strategies.

In this new era of precision healthcare, medical professionals can utilize advanced genomic data analysis, bioinformatics, and artificial intelligence to identify genetic markers, predict disease risks, and optimize treatment approaches. This holistic approach not only enhances patient outcomes but also helps in reducing healthcare costs by avoiding unnecessary treatments and interventions.

As the field of genetic genealogy continues to evolve, the potential for innovation and advancements in personalized medicine is vast. From tailoring medications based on an individual's genetic makeup to developing gene therapies for previously untreatable conditions, the possibilities are endless. By integrating genetic information into routine healthcare practices, we can revolutionize the way diseases are diagnosed, managed, and treated. The integration of genetic genealogy into healthcare practices holds immense promise for the future of personalized medicine. With a focus on individualized care, precise diagnostics, and targeted therapies, we can usher in an era of improved patient outcomes and enhanced overall healthcare experiences.

Key Market Challenges

Misuse of Data

The rapidly growing field of genetic genealogy testing offers individuals unprecedented insights into their ancestry and familial connections, but it also raises concerns about the potential misuse of sensitive genetic data. These concerns have the potential to decrease the demand for genetic genealogy testing services if not adequately addressed. Customers worry that their genetic information could be accessed by malicious actors, insurance companies, or employers, leading to discrimination or other harmful consequences. To mitigate this risk, genetic testing companies must implement robust data protection measures, including encryption, secure storage, and stringent access controls. Additionally, stringent data-sharing agreements should be established to ensure that genetic information is not sold or shared without explicit consent.

Another issue is the ethical use of genetic data in law enforcement investigations. The misuse of genetic databases for criminal investigations without informed consent has led to controversy and erosion of trust. Stricter regulations and guidelines governing the use of genetic data in criminal cases can help restore confidence in the industry.

To further reduce the chances of misuse, companies should educate consumers about the risks and benefits of genetic testing and provide clear, user-friendly privacy policies. Offering anonymous testing options or allowing users to control the level of data sharing can also alleviate privacy concerns.

High Costs of Genetic Testing

The high costs associated with genetic testing have the potential to significantly decrease the demand for genetic genealogy testing services, limiting access to valuable insights about one's ancestry and genetic heritage.

The upfront expense of genetic testing can be a substantial barrier for many individuals. High testing fees can dissuade potential customers from seeking out these services, especially those with limited financial resources. This can result in a skewed representation of genetic data, as only those who can afford it may participate, leading to a potential underrepresentation of certain populations. To address this issue, genetic testing companies should explore pricing models that make these services more affordable or offer discounts to individuals with lower incomes.

Moreover, there may be hidden costs associated with genetic testing. Some individuals may need to consult with genetic counselors or healthcare professionals to interpret their results, incurring additional expenses. To alleviate this burden, genetic testing companies should provide comprehensive and user-friendly reports that are easy for individuals to understand without the need for costly expert consultations. Insurance coverage is another concern. Many insurance policies do not cover genetic testing, which can further increase the overall cost for individuals. Advocacy for insurance coverage and changes in policy could help reduce this financial burden and encourage more people to consider genetic genealogy testing.

Key Market Trends

Development in Pharmacogenomics

Pharmacogenomics aims to tailor drug treatments to an individual's genetic profile, optimizing the efficacy and safety of medications. As this field advances, genetic testing becomes increasingly essential for healthcare providers to make informed decisions about drug prescriptions. Genetic genealogy testing, which already provides a wealth of genetic data, can serve as a foundational resource for pharmacogenomic assessments. This synergy between genetic genealogy and pharmacogenomics can drive greater interest and demand for genetic testing services.

Moreover, as pharmacogenomics evolves, individuals may be more inclined to undergo genetic testing to gain insights not only into their ancestry and familial connections but also into their genetic predispositions for drug responses. This dual benefit of genetic testing-both for ancestry exploration and personalized medicine-can make the investment in genetic testing more appealing to a broader audience. The integration of pharmacogenomics into routine healthcare can also lead to partnerships between genetic testing companies and healthcare providers. This collaboration could streamline the testing process and increase access to genetic information, further boosting demand.

Additionally, as more drugs are developed with a personalized approach in mind, pharmaceutical companies may encourage genetic testing to identify potential patient populations that would benefit most from their products. This could lead to incentives for individuals to undergo genetic testing.

Increasing Use for Family Tree Information

The increasing use of family tree information and the growing popularity of genealogical research can significantly boost the demand for genetic genealogy testing in the future. Genetic genealogy testing provides a scientific dimension to traditional genealogy research. It can confirm existing family tree information, resolve long-standing genealogical mysteries, and uncover previously unknown branches of the family tree. As genealogists and enthusiasts discover the value of DNA testing in complementing their research, the demand for genetic genealogy testing is likely to rise.

Genetic genealogy tests not only help individuals understand their ancestral origins but also connect them with living relatives. The prospect of discovering unknown cousins or distant family members can be a powerful motivator for people to undergo genetic testing. The more individuals realize the potential for these connections, the greater the demand for testing services. Many people are increasingly interested in exploring their cultural and heritage backgrounds. Genetic genealogy testing can provide insights into one's ethnic makeup, helping individuals better understand their roots and cultural heritage. This added layer of identity and connection can be a compelling reason to pursue genetic genealogy testing. Genetic genealogy testing has educational and recreational value. It can turn genealogy into a fascinating hobby and provide an educational experience for families, schools, and community groups. As more people become interested in these aspects, the demand for genetic genealogy testing kits for both personal and educational purposes is likely to increase.

Segmental Insights

Test Type Insights

Based on the test type, autosomal DNA testing dominates the market in 2022 due to its origin in the nucleus, representing an equal contribution of genetic material from both parents to their offspring. Each individual inherits 50% of their nuclear DNA from their father and 50% from their mother. This pattern continues through each generation, resulting in approximately 25% of DNA from each grandparent, 12.5% from each great-grandparent, and so on. Autosomal DNA testing is crucial for accurately estimating a family tree, as every individual carries a certain amount of equal autosomal DNA.

In contrast, Y-chromosome DNA testing focuses on the paternal line. The Y-chromosome is passed virtually unchanged from father to son, meaning that an individual shares the same Y-DNA as their father, grandfather, and great-grandfather, as well as their paternal uncle and grandfather's brothers. While this type of testing is valuable for studying family names in patrilineal societies, it does not provide information about which specific brother an individual descended from, as all males within the family share the same Y-DNA.

End User Insights

Based on the end user segment, Direct-to-consumer (DTC) genetic testing companies have rapidly dominated the genetic genealogy testing market for several compelling reasons. First and foremost, they offer unparalleled convenience. With DTC testing, individuals can order a DNA testing kit online or purchase one from a retail store, collect their DNA samples at home, and send them back for analysis. This streamlined process eliminates the need for healthcare professionals or intermediaries, making it accessible to a wide range of consumers.

Additionally, DTC testing companies have capitalized on the growing interest in ancestry exploration and personalized genetics. They provide comprehensive reports that not only reveal ancestral origins but also connect individuals with potential relatives in their databases, tapping into the emotional appeal of discovering long-lost family connections. Moreover, the competitive pricing of DTC genetic tests has democratized access to genetic information, making it affordable for a broader audience. The ease of online marketing and advertising has allowed these companies to reach a global customer base, further expanding their market dominance.

Regional Insights

The North America region is projected to dominate the market during the forecast period of 2024-2028. This can be attributed to the presence of key market players in the region, coupled with a well-developed healthcare infrastructure, which serves as the primary driver behind the substantial growth of the genetic genealogy market. Furthermore, robust economic growth and significant investments by major players have led to a notable upsurge in market expansion. Additionally, heightened consumer awareness regarding the advantages of quality treatment, combined with favorable reimbursement policies for healthcare services, has contributed to the upward trajectory of market growth.

Key Market Players

23&Me Inc.

Ancestry.com

MyHeritage

Sequencing. Com

FTDNA

DNASolves

Living DNA

FindmyPast

Familysearch

Geneanet

Report Scope:

In this report, the Global Genetic Genealogy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Genetic Genealogy Market, By Test Type:

• Autosomal DNA Test
• Y- chromosome DNA Test
• Mitochondrial DNA Test

Genetic Genealogy Market, By Application:

• Heredity & Genetic Disorders
• Paternal/Maternal Lineages
• Ancestral Origins
• Others

Genetic Genealogy Market, By End User:

• Direct-to-Consumer Testing Companies
• Law Enforcement Agencies
• Research Institutes & Academic Organizations
• Others

Genetic Genealogy Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Genetic Genealogy Market.

Available Customizations:

• Global Genetic Genealogy market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Genetic Genealogy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Autosomal DNA Test, Y- chromosome DNA Test, Mitochondrial DNA Test)
  • 5.2.2. By Application (Heredity & Genetic Disorders, Paternal/Maternal Lineages, Ancestral Origins, Others)
  • 5.2.3. By End User (Direct-to-Consumer Testing Companies, Law Enforcement Agencies, Research Institutes & Academic Organizations, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Market Map

6. North America Genetic Genealogy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Genetic Genealogy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Genetic Genealogy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Genetic Genealogy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Genetic Genealogy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Genetic Genealogy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Genetic Genealogy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Genetic Genealogy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Genetic Genealogy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Genetic Genealogy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Genetic Genealogy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Genetic Genealogy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Genetic Genealogy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Genetic Genealogy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Genetic Genealogy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Genetic Genealogy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Genetic Genealogy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Genetic Genealogy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Genetic Genealogy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Genetic Genealogy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Genetic Genealogy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Genetic Genealogy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Genetic Genealogy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Genetic Genealogy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Genetic Genealogy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. 23&Me Inc.
  • 15.5.2. Ancestry.com
  • 15.5.3. MyHeritage
  • 15.5.4. Sequencing. Com
  • 15.5.5. FTDNA
  • 15.5.6. DNASolves
  • 15.5.7. Living DNA
  • 15.5.8. FindmyPast
  • 15.5.9. Familysearch
  • 15.5.10. Geneanet

16. Strategic Recommendations

About Us & Disclaimer